Strategic Partnerships Astria Therapeutics has established key strategic partnerships with Ypsomed and Ichnos for the development of autoinjectors and licensing agreements, creating opportunities for collaborative sales efforts with partner companies.
Investor Backing With recent financing of $125 million and investments from entities like AJOVista LLC, Astria Therapeutics has demonstrated financial stability and growth potential, making them an attractive target for sales engagements around their innovative therapies.
Product Diversification Development of the OX40 portfolio for inflammatory and immune diseases showcases Astria Therapeutics' commitment to diversifying its product pipeline, presenting multiple avenues for sales expansion and revenue generation.
Opportunity for Upselling As Astria Therapeutics focuses on bringing therapies for rare diseases like Hereditary Angioedema, there is an opportunity for sales teams to upsell related products or combination therapies, leveraging the unique market positioning of the company.
Industry Relationships Being part of the biotechnology research sector and having associations with companies like Ypsomed, Ichnos, and Ajovista, Astria Therapeutics can leverage industry relationships to explore cross-selling opportunities, expanding their market reach and revenue streams.
62
$10M
770$100M$1B
11$10M
157$10M$50M
18
69$10M$50M
2Astria Therapeutics, Inc. uses 8 technology products and services including jsDelivr, Unpkg, Drupal, and more. Explore Astria Therapeutics, Inc.'s tech stack below.
| Astria Therapeutics, Inc. Email Formats | Percentage |
| FLast@catabasis.com | 83% |
| Last@catabasis.com | 16% |
| FMLast@catabasis.com | 1% |
| FLast@astriatx.com | 97% |
| Last.First@astriatx.com | 3% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
At Astria Therapeutics, our team is focused on bringing therapies with the potential to improve the quality of life to patients and families affected by Hereditary Angioedema (HAE) and rare allergic and immunological diseases. Our name originates from the Greek word for star, and patients are guiding stars who guide us in the development of life-changing therapies. Learn more at www.astriatx.com
Company Overview
Media & News
Funding & FinancialsAstria Therapeutics, Inc. has raised a total of $125M of funding over 17 rounds. Their latest funding round was raised on Jan 30, 2024 in the amount of $125M.
Astria Therapeutics, Inc.'s revenue is in the range of $10M
Funding & FinancialsAstria Therapeutics, Inc. has raised a total of $125M of funding over 17 rounds. Their latest funding round was raised on Jan 30, 2024 in the amount of $125M.
Astria Therapeutics, Inc.'s revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com